Growing community of inventors

Berlin, Germany

Thomas Zollner

Average Co-Inventor Count = 4.80

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Thomas ZollnerHartmut Rehwinkel (3 patents)Thomas ZollnerMarkus Berger (3 patents)Thomas ZollnerJorma Hassfeld (3 patents)Thomas ZollnerHeike Schäcke (2 patents)Thomas ZollnerEkkehard May (2 patents)Thomas ZollnerHeike Schaecke (1 patent)Thomas ZollnerMarkus Koch (1 patent)Thomas ZollnerMichaele Peters (1 patent)Thomas ZollnerBkkehard May (1 patent)Thomas ZollnerThomas Zollner (4 patents)Hartmut RehwinkelHartmut Rehwinkel (53 patents)Markus BergerMarkus Berger (37 patents)Jorma HassfeldJorma Hassfeld (5 patents)Heike SchäckeHeike Schäcke (5 patents)Ekkehard MayEkkehard May (2 patents)Heike SchaeckeHeike Schaecke (16 patents)Markus KochMarkus Koch (3 patents)Michaele PetersMichaele Peters (3 patents)Bkkehard MayBkkehard May (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Bayer Pharma Aktiengesellschaft (2 from 378 patents)

2. Astrazeneca Ab (1 from 1,503 patents)

3. Bayer Intellectual Property Gmbh (1 from 721 patents)

4. Bayer Schering Pharma Ag (1 from 192 patents)


4 patents:

1. 11266646 - Use of chymase inhibitors for the treatment of endometriosis, post operative fibrosis and diseases which are characterized by fibrosis formation

2. RE47047 - 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

3. 8680117 - [object Object]

4. 8394958 - 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/16/2026
Loading…